Literature DB >> 16427630

The p53-inducible E3 ubiquitin ligase p53RFP induces p53-dependent apoptosis.

Jun Huang1, Liang-Guo Xu, Ting Liu, Zhonghe Zhai, Hong-Bing Shu.   

Abstract

Recently, it has been shown that really interesting new gene (RING)-in between ring finger (IBR)-RING domain-containing proteins, such as Parkin and Parc, are E3 ubiquitin ligases and are involved in regulation of apoptosis. In this report, we show that p53-inducible RING-finger protein (p53RFP), a p53-inducible E3 ubiquitin ligase, induces p53-dependent but caspase-independent apoptosis. p53RFP contains an N-terminal RING-IBR-RING domain and an uncharacterized, evolutionally highly conserved C-terminal domain. p53RFP interacts with E2 ubiquitin-conjugating enzymes UbcH7 and UbcH8 but not with UbcH5, and this interaction is mediated through the RING-IBR-RING domain of p53RFP. Interestingly, the conserved C-terminal domain of p53RFP is required and sufficient for p53RFP-mediated apoptosis, suggesting p53RFP-mediated apoptosis does not require its E3 ubiquitin ligase activity. Together with a recent report showing that p53RFP is involved in ubiquitination and degradation of p21, a p53 downstream protein promoting growth arrest and antagonizing apoptosis, our findings suggest that p53RFP is involved in switching a cell from p53-mediated growth arrest to apoptosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16427630     DOI: 10.1016/j.febslet.2005.09.105

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  21 in total

1.  IBRDC2, an IBR-type E3 ubiquitin ligase, is a regulatory factor for Bax and apoptosis activation.

Authors:  Giovanni Benard; Albert Neutzner; Guihong Peng; Chunxin Wang; Ferenc Livak; Richard J Youle; Mariusz Karbowski
Journal:  EMBO J       Date:  2010-03-18       Impact factor: 11.598

2.  The basis for selective E1-E2 interactions in the ISG15 conjugation system.

Authors:  Larissa A Durfee; Melissa L Kelley; Jon M Huibregtse
Journal:  J Biol Chem       Date:  2008-06-26       Impact factor: 5.157

3.  Differentiation of single cell derived human mesenchymal stem cells into cells with a neuronal phenotype: RNA and microRNA expression profile.

Authors:  Francesca Crobu; Veronica Latini; Maria Franca Marongiu; Valeria Sogos; Franca Scintu; Susanna Porcu; Carla Casu; Manuela Badiali; Adele Sanna; Maria Francesca Manchinu; Maria Serafina Ristaldi
Journal:  Mol Biol Rep       Date:  2011-07-20       Impact factor: 2.316

Review 4.  RBR E3-ligases at work.

Authors:  Judith J Smit; Titia K Sixma
Journal:  EMBO Rep       Date:  2014-01-27       Impact factor: 8.807

5.  Differential control of TAp73 and DeltaNp73 protein stability by the ring finger ubiquitin ligase PIR2.

Authors:  Berna S Sayan; Ai Li Yang; Franco Conforti; Paola Tucci; Maria Cristina Piro; Gareth J Browne; Massimiliano Agostini; Sergio Bernardini; Richard A Knight; Tak W Mak; Gerry Melino
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-06       Impact factor: 11.205

Review 6.  Multiple degradation pathways regulate versatile CIP/KIP CDK inhibitors.

Authors:  Natalia G Starostina; Edward T Kipreos
Journal:  Trends Cell Biol       Date:  2011-12-09       Impact factor: 20.808

Review 7.  Exploitation of eukaryotic subcellular targeting mechanisms by bacterial effectors.

Authors:  Stuart W Hicks; Jorge E Galán
Journal:  Nat Rev Microbiol       Date:  2013-05       Impact factor: 60.633

8.  A gene signature-based approach identifies mTOR as a regulator of p73.

Authors:  Jennifer M Rosenbluth; Deborah J Mays; Maria F Pino; Luo Jia Tang; Jennifer A Pietenpol
Journal:  Mol Cell Biol       Date:  2008-08-04       Impact factor: 4.272

9.  Ubiquitin control of S phase: a new role for the ubiquitin conjugating enzyme, UbcH7.

Authors:  Elizabeth A Whitcomb; Allen Taylor
Journal:  Cell Div       Date:  2009-08-07       Impact factor: 5.130

10.  Regulation of RNF144A E3 Ubiquitin Ligase Activity by Self-association through Its Transmembrane Domain.

Authors:  Shiuh-Rong Ho; Yu-Ju Lee; Weei-Chin Lin
Journal:  J Biol Chem       Date:  2015-07-27       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.